Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Dec;55(12):3174–3180. doi: 10.1128/iai.55.12.3174-3180.1987

Effects of inhibitors of tumoricidal activity upon schistosomulum killing by activated macrophages.

S L James 1, J A Glaven 1
PMCID: PMC260045  PMID: 3119500

Abstract

Larvae of the helminth parasite Schistosoma mansoni are efficiently killed in vitro by lymphokine-activated macrophages, leading to the hypothesis that these cells may participate in the effector mechanism of protective immunity against schistosomiasis. Larvacidal activity has also been demonstrated in the IC-21 macrophage cell line in the absence of a demonstrable respiratory burst, indicating that macrophages possess nonoxidative mechanisms of schistosomulum killing. In this study, we demonstrated that IC-21 larval killing was most effective when contact was allowed between cells and target. Nonoxidative larvacidal activity was prevented by protein synthesis inhibitors, by the inhibition of microtubule polymerization, and by tosyllysylchloromethylketone but not by other inhibitors or substrates of tryptic or chymotryptic protease activity. The addition of excess iron to the culture also prevented IC-21-mediated larval killing, suggesting that the production of an iron-binding molecule may be involved. In contrast, the addition of excess thymidine or arginine did not reverse macrophage larvacidal activity, nor did lysosomotropic agents that depress the activity of acid hydrolases. Under appropriate conditions of activation and surface membrane stimulation, IC-21 cells could be induced to release soluble cytotoxic factors retaining larvacidal activity. These observations provide insight into the mechanism of macrophage-mediated schistosome killing, in comparison to the cytotoxic mechanisms described in the better-studied tumoricidal models, and supply a basis for further biochemical investigation of macrophage function against a multicellular target.

Full text

PDF
3174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Kao K. J., Farb R., Pizzo S. V. Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. J Immunol. 1980 Jan;124(1):293–300. [PubMed] [Google Scholar]
  2. Behin R., Mauel J., Sordat B. Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp Parasitol. 1979 Aug;48(1):81–91. doi: 10.1016/0014-4894(79)90057-2. [DOI] [PubMed] [Google Scholar]
  3. Bout D. T., Joseph M., David J. R., Capron A. R. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages. J Immunol. 1981 Jul;127(1):1–5. [PubMed] [Google Scholar]
  4. Currie G. A. Activated macrophages kill tumour cells by releasing arginase. Nature. 1978 Jun 29;273(5665):758–759. doi: 10.1038/273758a0. [DOI] [PubMed] [Google Scholar]
  5. Drapier J. C., Hibbs J. B., Jr Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest. 1986 Sep;78(3):790–797. doi: 10.1172/JCI112642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Freedman V. H., Gorrell T. E., Nathan C. F., Copeland C. S., Silverstein S. C. Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions. J Exp Med. 1984 Jul 1;160(1):94–107. doi: 10.1084/jem.160.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hibbs J. B., Jr, Taintor R. R., Chapman H. A., Jr, Weinberg J. B. Macrophage tumor killing: influence of the local environment. Science. 1977 Jul 15;197(4300):279–282. doi: 10.1126/science.327547. [DOI] [PubMed] [Google Scholar]
  8. Hiserodt J. C., Britvan L. J., Targan S. R. Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages. J Immunol. 1982 Nov;129(5):2266–2270. [PubMed] [Google Scholar]
  9. James S. L. Activated macrophages as effector cells of protective immunity to schistosomiasis. Immunol Res. 1986;5(2):139–148. doi: 10.1007/BF02917588. [DOI] [PubMed] [Google Scholar]
  10. James S. L., Correa-Oliveira R., Sher A., Medvitz L. A., McCall R. D. Genetic association of defects in macrophage larvicidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain mice. Infect Immun. 1987 Aug;55(8):1884–1889. doi: 10.1128/iai.55.8.1884-1889.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. James S. L. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages. J Immunol. 1986 May 15;136(10):3872–3877. [PubMed] [Google Scholar]
  12. James S. L. Parasiticidal activity of macrophages against schistosomes. Methods Enzymol. 1986;132:649–658. doi: 10.1016/s0076-6879(86)32048-2. [DOI] [PubMed] [Google Scholar]
  13. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marino P. A., Adams D. O. Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro. I. Conditions of binding and its selectivity. Cell Immunol. 1980 Aug 15;54(1):11–25. doi: 10.1016/0008-8749(80)90185-9. [DOI] [PubMed] [Google Scholar]
  15. Mauel J., Defendi V. Infection and transformation of mouse peritoneal macrophages by simian virus 40. J Exp Med. 1971 Aug 1;134(2):335–350. doi: 10.1084/jem.134.2.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McLaren D. J., James S. L. Ultrastructural studies of the killing of schistosomula of Schistosoma mansoni by activated macrophages in vitro. Parasite Immunol. 1985 May;7(3):315–331. doi: 10.1111/j.1365-3024.1985.tb00079.x. [DOI] [PubMed] [Google Scholar]
  17. Nathan C. F., Murray H. W., Cohn Z. A. The macrophage as an effector cell. N Engl J Med. 1980 Sep 11;303(11):622–626. doi: 10.1056/NEJM198009113031106. [DOI] [PubMed] [Google Scholar]
  18. Olds G. R., Ellner J. J., Kearse L. A., Jr, Kazura J. W., Mahmoud A. A. Role of arginase in killing of schistosomula of Schistosoma mansoni. J Exp Med. 1980 Jun 1;151(6):1557–1562. doi: 10.1084/jem.151.6.1557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pincus S. H., Butterworth A. E., David J. R., Robbins M., Vadas M. A. Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism. J Immunol. 1981 May;126(5):1794–1799. [PubMed] [Google Scholar]
  20. Quan P. C., Ishizaka T., Bloom B. R. Studies on the mechanism of NK cell lysis. J Immunol. 1982 Apr;128(4):1786–1791. [PubMed] [Google Scholar]
  21. Reaven E. Stereological analysis of microtubules in cells with special reference to their possible role in secretion. Methods Cell Biol. 1982;25(Pt B):273–283. doi: 10.1016/s0091-679x(08)61429-6. [DOI] [PubMed] [Google Scholar]
  22. Scott P., James S., Sher A. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur J Immunol. 1985 Jun;15(6):553–558. doi: 10.1002/eji.1830150605. [DOI] [PubMed] [Google Scholar]
  23. Shaw E. Selective chemical modification of proteins. Physiol Rev. 1970 Apr;50(2):244–296. doi: 10.1152/physrev.1970.50.2.244. [DOI] [PubMed] [Google Scholar]
  24. Stadecker M. J., Calderon J., Karnovsky M. L., Unanue E. R. Synthesis and release of thymidine by macrophages. J Immunol. 1977 Nov;119(5):1738–1743. [PubMed] [Google Scholar]
  25. Walton E., Gladstone G. P. Factors affecting the susceptibility of staphylococci to killing by the cationic proteins from rabbit polymorphonuclear leucocytes: the effects of alteration of cellular energetics and of various iron compounds. Br J Exp Pathol. 1976 Oct;57(5):560–570. [PMC free article] [PubMed] [Google Scholar]
  26. Zacharchuk C. M., Drysdale B. E., Mayer M. M., Shin H. S. Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6341–6345. doi: 10.1073/pnas.80.20.6341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. de Duve C., de Barsy T., Poole B., Trouet A., Tulkens P., Van Hoof F. Commentary. Lysosomotropic agents. Biochem Pharmacol. 1974 Sep 15;23(18):2495–2531. doi: 10.1016/0006-2952(74)90174-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES